Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$71.71
Market cap
$2.22B
P/E Ratio
16.75
Dividend/share
$0.8
EPS
$4.28
Enterprise value
$3.12B
CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties,
Highlights
The net income has soared by 127% year-on-year and by 34% since the previous quarter
CNMD's EPS has soared by 121% YoY and by 33% QoQ
CNMD's quick ratio is up by 39% YoY but it is down by 5% QoQ
Key stats
What are the main financial stats of CNMD
Market
Valuations
Earnings
Shares outstanding
30.89M
Market cap
$2.22B
Enterprise value
$3.12B
Price to earnings (P/E)
16.75
Price to book (P/B)
2.37
Price to sales (P/S)
1.72
EV/EBIT
15.74
EV/EBITDA
14.54
EV/Sales
2.42
Revenue
$1.29B
EBIT
$198.01M
EBITDA
$214.47M
Free cash flow
$166.13M
Per share
Balance sheet
Liquidity
EPS
$4.28
Free cash flow per share
$5.38
Book value per share
$30.26
Revenue per share
$41.75
TBVPS
$28.63
Total assets
$2.32B
Total liabilities
$1.38B
Debt
$940.81M
Equity
$932.9M
Working capital
$358.69M
Debt to equity
1.01
Current ratio
2.27
Quick ratio
0.96
Net debt/EBITDA
4.21
Margins
Efficiency
Dividend
EBITDA margin
16.7%
Gross margin
55.7%
Net margin
10.2%
Operating margin
15.4%
Return on assets
5.7%
Return on equity
15%
Return on invested capital
13.1%
Return on capital employed
9.7%
Return on sales
15.4%
Dividend yield
1.12%
DPS
$0.8
Payout ratio
18.7%
CNMD stock price
How has the CONMED stock price performed over time
Intraday
1.44%
1 week
0.73%
1 month
12.33%
1 year
-33.75%
YTD
-34.52%
QTD
-0.29%
Financial performance
How have CONMED's revenue and profit performed over time
Revenue
$1.29B
Gross profit
$716.86M
Operating income
$198.01M
Net income
$131.74M
Gross margin
55.7%
Net margin
10.2%
The operating income has soared by 186% year-on-year and by 22% since the previous quarter
The operating margin has surged by 161% year-on-year and by 21% since the previous quarter
The net income has soared by 127% year-on-year and by 34% since the previous quarter
The company's net margin has surged by 104% YoY and by 32% QoQ
Growth
What is CONMED's growth rate over time
Valuation
What is CONMED stock price valuation
P/E
16.75
P/B
2.37
P/S
1.72
EV/EBIT
15.74
EV/EBITDA
14.54
EV/Sales
2.42
CNMD's EPS has soared by 121% YoY and by 33% QoQ
The stock's price to earnings (P/E) is 96% less than its 5-year quarterly average of 474.9 and 44% less than its last 4 quarters average of 30.1
The stock's price to book (P/B) is 41% less than its 5-year quarterly average of 4.0 and 18% less than its last 4 quarters average of 2.9
CNMD's equity is up by 17% YoY and by 6% from the previous quarter
CNMD's P/S is 43% less than its 5-year quarterly average of 3.0 and 14% less than its last 4 quarters average of 2.0
CNMD's revenue is up by 10% year-on-year
Efficiency
How efficient is CONMED business performance
CNMD's return on invested capital has surged by 185% year-on-year and by 20% since the previous quarter
CNMD's ROS has soared by 161% YoY and by 21% QoQ
CNMD's return on assets has surged by 128% year-on-year and by 33% since the previous quarter
The ROE has soared by 100% YoY and by 28% from the previous quarter
Dividends
What is CNMD's dividend history
DPS
$0.8
Dividend yield
1.12%
Payout ratio
18.7%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did CONMED financials performed over time
CNMD's total assets is 67% greater than its total liabilities
CNMD's quick ratio is up by 39% YoY but it is down by 5% QoQ
The current ratio has grown by 37% YoY but it has contracted by 3% from the previous quarter
The company's debt to equity fell by 20% YoY and by 8% QoQ
CNMD's equity is up by 17% YoY and by 6% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.